Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study Ninety patients were randomly assigned. Toxicity ...
Dec. 4, 2003 (San Antonio) — Docetaxel (Taxotere) produced better overall survival and longer time to progression than paclitaxel (Taxol) in a randomized head-to-head trial of the two taxanes widely ...
The company's docetaxel injection is the first nonalcohol formulation approved in the U.S., according to Teikoku. It also requires no prior dilution and is ready to add to the infusion solution. It is ...
BRIDGEWATER, NJ – June 5, 2004 – Aventis announced today the results of a phase III trial using Taxotere® (docetaxel) Injection Concentrate when added to a standard therapy for nonresectable locally ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Docetaxel prolonged DFS and OS when added to radiation for cisplatin-ineligible patients with locally ...
Source: Getty Images Investigators studied the effect of sequential valrubicin and docetaxel in patients with recurrent NMIBC following treatment with intravesical bacillus Calmette-Guérin and/or ...
AMSTERDAM--(BUSINESS WIRE)--Modra Pharmaceuticals (“Modra”) today announced positive data from its Phase IIb trial evaluating its boosted oral taxane therapeutic, ModraDoc006/r, in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback